Laure Marignol

Prof. Laure Marignol


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2014 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
VBVictoria Anastasia Belle
Victoria Anastasia Belle
NMNiamh McDermott
Niamh McDermott
AMArmelle Meunier
Armelle Meunier
LMLaure Marignol
Laure Marignol

1 June 2008 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
LMLaure Marignol
Laure Marignol
MCM. Coffey
M. Coffey
MLM. Lawler
M. Lawler
DHD. Hollywood
D. Hollywood

17 June 2012 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
NLNiamh Lynam-Lennon
Niamh Lynam-Lennon
JRJohn V. Reynolds
John V. Reynolds
LMLaure Marignol
Laure Marignol
OSOrla M. Sheils
Orla M. Sheils
GPGraham P. Pidgeon
Graham P. Pidgeon
Stephen MaherStephen Maher
Stephen Maher

28 May 2013 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
LMLaure Marignol
Laure Marignol
KRKarla Rivera-Figueroa
Karla Rivera-Figueroa
TLThomas Lynch
Thomas Lynch
DHDonal Hollywood
Donal Hollywood

1 November 2010 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
LMLynn M. Martin
Lynn M. Martin
BMBrian Marples
Brian Marples
MCMary Coffey
Mary Coffey
MLMark Lawler
Mark Lawler
TLThomas H. Lynch
Thomas H. Lynch
LMLaure Marignol
Laure Marignol

3 December 2010 in Radiation Research
Verified
Journal Article
Closed access
PDF file
NLNiamh Lynam-Lennon
Niamh Lynam-Lennon
JRJohn V. Reynolds
John V. Reynolds
GPGraham P. Pidgeon
Graham P. Pidgeon
JLJoanne Lysaght
Joanne Lysaght
LMLaure Marignol
Laure Marignol
Stephen MaherStephen Maher
Stephen Maher
To study radioresistance in esophageal adenocarcinoma, we generated an isogenic cell line model by exposing OE33 esophageal adenocarcinoma cells to clinically relevant fractionated doses of radiation (cumulative dose 50 Gy). A clonogenic assay confirmed enhanced survival of the radioresistant OE33 subline (OE33 R). To our knowledge, we are the first to generate an isogenic model of radioresistance in esophageal adenocarcinoma. This model system was characterized in terms of growth, cell cycle distribution and checkpoint operation, apoptosis, reactive oxygen species generation and scavenging, and DNA damage. While similar properties were found for both the parental OE33 (OE33 P) cells and radioresistant OE33 R cells, OE33 R cells demonstrated greater repair of radiation-induced DNA damage. Our results suggest that the radioresistance of OE33 R cells is due at least in part to increased DNA repair.